Trials / Completed
CompletedNCT04091178
Vitamin D Supplementation to Correct the Vitamin D Deficiency for Breast Cancer
A PHASE II Multicentric Trial Evaluating a High Dose Vitamin D Supplementation to Correct the Vitamin D Deficiency for Breast Cancer Treated by Adjuvant Chemotherapy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An open clinical trial not randomized, multicentric. This study search to evaluate vitamin D supplementation efficacy at high dose (UVEDOSE, colecalciferol, oral solution at 100 000 UI) of vitamin D on day 1 of each cycles for breast cancer treated adjuvant chemotherapy. A calcium supplementation will be prescribed in parallel. An initial dosage of 25OH vitamin D rate will be done and a vitamin-calcic dosage will done on day 1 of every cycles of chemotherapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | VITAMIN D | ORAL SOLUTION (2 ml) at 100.000 UI |
Timeline
- Start date
- 2013-10-10
- Primary completion
- 2015-06-11
- Completion
- 2017-03-16
- First posted
- 2019-09-16
- Last updated
- 2019-09-16
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04091178. Inclusion in this directory is not an endorsement.